Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study

AIM: To assess in real life the rate of hypoglycemia during Ramadan in patients with type 2 diabetes (T2DM) in France, according to their ongoing dual therapy of metformin-vildagliptin or metformin-sulfonylurea/glinide (IS). METHODS: Prospective, non-interventional study with 2 visits (within 8 week...

Descripción completa

Detalles Bibliográficos
Autores principales: Halimi, Serge, Levy, Marc, Huet, Dominique, Quéré, Stéphane, Dejager, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889327/
https://www.ncbi.nlm.nih.gov/pubmed/23996548
http://dx.doi.org/10.1007/s13300-013-0038-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889327/
https://www.ncbi.nlm.nih.gov/pubmed/23996548
http://dx.doi.org/10.1007/s13300-013-0038-7

Ejemplares similares